Prostate Cancer Research

PSA testing for prostate cancer detects elevated prostate-specific antigen levels but is controversial due to false positives and non-cancerous causes like enlarged prostates. Experts recommend men aged 55-69 and those at higher risk (family history, African American descent) discuss screening with healthcare providers, as early detection can improve outcomes for aggressive cancers.

PSA testing for prostate cancer is controversial due to its potential for false positives and inability to distinguish between life-threatening and non-threatening cancers. Experts like Dr. Christopher Warlick highlight that elevated PSA levels can result from noncancerous conditions, and the United States Preventive Services Task Force recommends men aged 55-69 discuss screening with their providers, particularly those at higher risk such as African American men or those with family histories of prostate cancer.

PSA testing for prostate cancer is controversial due to its potential for false positives and non-cancerous causes of elevated PSA levels. Experts recommend men aged 55-69 discuss screening with providers, especially those at higher risk, such as African American men or those with family history. The test can detect life-threatening cancers early but may lead to unnecessary biopsies or treatment for slow-growing, non-threatening cancers.